Displaying 86 - 90 of 198
Fri 18 March 2016
Alex Ford, Chief Executive of Pancreatic Cancer UK comments on the decision to retain routine NHS access to Abraxane for eligible patients in Wales.Read More about 'Abraxane retained for use on NHS across Wales'
Fri 04 March 2016
New research offers an insight into how our immune system might be able to recognise unique markings within a tumour, allowing the body to fight cancer.Read More about 'New research insight into the power of our immune system to fight cancer'
Thu 25 February 2016
Pancreatic Cancer UK is today revealing its new brand identity, which will help the charity transform the future for patients and families over the next five years.Read More about 'Pancreatic Cancer UK unveils new brand identity in its 10th anniversary year'
Wed 24 February 2016
Researchers have reclassified pancreatic cancer as four distinct types, a discovery that could offer new opportunities to treat the disease, according to their study published in Nature.Read More about 'Identification of four pancreatic cancer subtypes offers treatment insight'
Mon 22 February 2016
Pancreatic cancer cases up a third to 12,000 a year by 2030, just 600 of those patients set to live 5 years.Read More about 'Pancreatic cancer cases up a third by 2030'